NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 248 filers reported holding NEKTAR THERAPEUTICS in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $25,000 | -86.6% | 1,505 | -81.4% | 0.00% | -90.0% |
| Q2 2020 | $187,000 | -40.3% | 8,078 | -44.3% | 0.01% | -16.7% |
| Q4 2019 | $313,000 | +7725.0% | 14,506 | +14406.0% | 0.01% | – |
| Q2 2019 | $4,000 | -82.6% | 100 | -73.1% | 0.00% | -100.0% |
| Q3 2018 | $23,000 | -92.6% | 372 | -87.3% | 0.00% | -95.7% |
| Q1 2018 | $312,000 | +5100.0% | 2,937 | +2927.8% | 0.02% | – |
| Q4 2017 | $6,000 | -98.5% | 97 | -99.4% | 0.00% | -100.0% |
| Q3 2017 | $398,000 | -55.4% | 16,587 | -63.7% | 0.04% | -57.6% |
| Q2 2017 | $893,000 | +116.7% | 45,683 | +160.0% | 0.08% | +117.9% |
| Q1 2017 | $412,000 | +118.0% | 17,569 | +14.3% | 0.04% | +69.6% |
| Q4 2016 | $189,000 | +20.4% | 15,368 | +39.1% | 0.02% | +4.5% |
| Q2 2016 | $157,000 | -13.3% | 11,048 | -16.1% | 0.02% | -12.0% |
| Q1 2016 | $181,000 | -78.2% | 13,172 | -73.3% | 0.02% | -80.6% |
| Q4 2015 | $831,000 | +164.6% | 49,339 | +72.3% | 0.13% | +180.4% |
| Q3 2015 | $314,000 | -41.2% | 28,633 | -33.0% | 0.05% | -38.7% |
| Q2 2015 | $534,000 | +81.6% | 42,711 | +59.9% | 0.08% | +82.9% |
| Q1 2015 | $294,000 | -31.5% | 26,711 | -3.4% | 0.04% | -34.9% |
| Q4 2014 | $429,000 | +31.6% | 27,663 | +2.4% | 0.06% | +37.0% |
| Q3 2014 | $326,000 | -17.5% | 27,013 | -12.3% | 0.05% | -11.5% |
| Q2 2014 | $395,000 | -35.5% | 30,785 | -39.0% | 0.05% | -36.6% |
| Q1 2014 | $612,000 | +132.7% | 50,505 | +117.6% | 0.08% | +90.7% |
| Q4 2013 | $263,000 | +8.7% | 23,212 | 0.0% | 0.04% | +10.3% |
| Q3 2013 | $242,000 | -64.0% | 23,212 | -60.1% | 0.04% | -72.9% |
| Q2 2013 | $673,000 | -32.2% | 58,235 | -35.5% | 0.14% | -22.2% |
| Q1 2013 | $993,000 | – | 90,235 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |